The combination of Rosuvastatin Calcium Tablets and Ezetimibe Tablets can have some therapeutic effects on hypercholesterolemia, with side effects such as dizziness and headache, which vary from person to person. Rosuvastatin Calcium Tablet is mainly used for the treatment of primary hypercholesterolemia, pure familial hypercholesterolemia, mixed dyslipidemia, etc. It should be contraindicated in patients with myopathy, cyclosporine concomitant users, patients with active liver disease, patients with severe renal impairment, pregnant and lactating women, and those who are allergic to the product and other groups. Ezetimibe can be used with dietary control, combined with statins for the adjunctive treatment of primary hypercholesterolemia, pure familial hypercholesterolemia, and pure glutamatemia. It should be contraindicated in those who are allergic to the product, those with active liver disease, and those with unexplained persistent elevation of serum transaminases. Therefore, Rosuvastatin Calcium Tablets combined with Ezetimibe Tablets can be used for the treatment of primary hypercholesterolemia, pure familial hypercholesterolemia and other diseases, but the effect of the drug varies from person to person. Common adverse effects include diabetes mellitus, dizziness, headache, headache, myalgia, constipation, nausea, abdominal pain, diarrhea, abdominal distension, fatigue, elevated aminotransferases, fatigue, and peripheral edema. The occurrence of specific side effects also varies from person to person, and the specific use of the drug in question should be under the guidance of a specialist, not unauthorized use of the drug.